Evolv Technology (EVLV) Q1 2026 earnings review
Revenue Surges on Direct Sales, but ARR Growth Lags
Evolv delivered a significant top-line beat in Q1, accelerating revenue growth to 45% YoY ($46.3M) and prompting a full-year guidance raise. However, the quality of this beat requires scrutiny. The headline surge was overwhelmingly driven by a 142% spike in non-recurring revenue, an artifact of the company's shift toward a direct fulfillment model that recognizes hardware sales upfront. Meanwhile, the underlying subscription engine—Annual Recurring Revenue (ARR)—grew at a stable but slower 20% pace. Profitability is holding steady, with Adjusted EBITDA margins hitting 8.5%, proving the business is structurally sound post-restructuring. Yet, an $11.8M build-up in Accounts Receivable dragged operating cash flow into negative territory. Management is trading short-term margin and predictable revenue optics for higher lifetime customer value.
🐂 Bull Case
Evolv generated $3.9M in Adjusted EBITDA (8.5% margin), up from $2.1M a year ago. The company has now demonstrated consistent, positive operating leverage across multiple quarters despite shifting go-to-market mechanics.
Raising the full-year revenue outlook by $3M to $175-$180M in Q1 signals strong pipeline visibility and confidence in the direct fulfillment transition.
🐻 Bear Case
The massive 45% revenue growth is a mirage of accounting. Non-recurring revenue grew 142%, while recurring revenue grew only 21%. The narrative of a 'predictable software-like subscription model' is becoming blurred by heavy upfront hardware sales.
Despite posting nearly $4M in Adjusted EBITDA, Operating Cash Flow was $(3.2)M. A sudden $11.9M spike in accounts receivable suggests cash collections aren't keeping pace with recognized revenue.
⚖️ Verdict: ⚪
Neutral. The business is stabilizing, and capturing 100% of ARPU via direct fulfillment is a smart long-term NPV move. However, the widening gap between headline revenue growth and ARR growth means investors are paying software multiples for what currently looks increasingly like hardware economics.
Key Themes
The ARR vs. Revenue Disconnect
Evolv is actively shifting its go-to-market strategy from a distribution-fulfilled model to a direct-fulfilled purchase-subscription model. This captures more total cash over the life of a contract but forces upfront revenue recognition. The result: Q1 non-recurring revenue accelerated 142% YoY to $15.1M, while recurring revenue was stable at 21% growth. If this trend continues, Evolv's financials will become lumpier and harder to predict, contradicting the 'pure subscription' thesis.
Direct Fulfillment Driving Top-Line and LTV
Management expects 55% of 2026 unit deployments to use the purchase-subscription model. By cutting out the middleman, Evolv captures 100% of the Average Revenue Per Unit (ARPU). While this creates near-term gross margin noise, it significantly improves lifetime cash flow per unit and anchors the raised $175-$180M FY26 revenue guidance.
eXpedite Adoption Expanding the TAM
The Evolv eXpedite autonomous bag screening system is successfully driving land-and-expand motions. In previous quarters, attach rates for eXpedite to the core Express product were exceptionally high. The press release explicitly cites eXpedite adoption as a primary catalyst for Q1's strong new customer acquisition.
Working Capital Soaks Up Cash Flow
Operating Cash Flow is decelerating relative to earnings. Net Cash Used in Operating Activities was $(3.2)M in 26Q1, worse than the $(2.5)M a year ago. The primary culprit is an $11.9M drag from Accounts Receivable. As the company pushes more direct hardware sales, working capital needs will intensify. The $61.1M liquidity cushion is healthy, but the cash burn needs close monitoring.
Macro Tailwinds in Healthcare & Education
Demand remains structurally supported by legislative and safety pressures. While not explicitly quantified in the Q1 release, Evolv previously noted that state-level mandates (like California's hospital weapons detection law) and persistent safety concerns in K-12 are effectively forcing facilities into long-term infrastructure upgrades. This insulates Evolv from standard enterprise IT budget cuts.
Other KPIs
Stable. Grew 20% YoY, perfectly aligning with management's full-year expectation of 20-25% growth. This metric is the true north star for Evolv's intrinsic value, cutting through the noise of hardware sales timing.
Accelerating. Up from $2.1M in Q1'25. Adjusted EBITDA margin came in at 8.5%, proving that the steep drop in operating expenses enacted during the 2025 restructuring is sticking, delivering true operating leverage.
Guidance
Accelerating vs prior guide. The company raised the outlook from $172-$178M, implying 20% to 23% YoY growth. However, given Q1 grew at 45%, this guidance implies a stark deceleration in revenue growth for the remaining three quarters (implied ~15-16% growth) as hardware order comps get tougher.
Stable. Unchanged from prior guidance, implying 20% to 25% YoY growth. This confirms that the Q1 revenue beat was entirely driven by upfront purchase timing rather than an acceleration in recurring contract volume.
Stable. Unchanged from prior estimates. With Q1 landing at 8.5%, management is essentially projecting flat sequential margins for the rest of the year.
Key Questions
Accounts Receivable Build
Accounts Receivable increased by nearly $12 million in a single quarter. Is this purely a function of back-end weighted hardware bookings, or are there extended payment terms being offered to incentivize direct fulfillment conversions?
Implied Growth Deceleration
You delivered 45% revenue growth in Q1 but only raised the full-year guide by $3M at the midpoint. Does this imply a rapid deceleration to the mid-teens for the remainder of the year, or is this conservatism around hardware delivery timing?
eXpedite Standalone Gross Margins
As the eXpedite product gains critical mass, what does the standalone gross margin profile look like today versus the mature Gen2 Express units?